Proteon Therapeutics lands $19M in VC
|
VENTURE CAPITAL |
|||
|
COMPANY |
AMOUNT/ROUND |
LEAD INVESTORS |
DESCRIPTION |
|
Proteon Therapeutics
|
$19M
|
TVM Capital and Skyline Ventures |
Proteon will use the money to hire more researchers and advance development of its dialysis therapy. |
|
PanGenetics BV
|
€13M
|
ABN AMRO Capital |
The funds will enable PanGenetics to continue clinical development of its human CD40 antagonist, PG102, with a view to filing an IND in the first quarter of 2007. |
|
Ingenium
|
€9.2M
|
HBM Bioventures and TVM Capital |
The funding will enable Ingenium to reach the critical next step in the development of treatments for pain and inflammatory diseases. |